CN102802625A - 可可碱和抗组胺剂的治疗组合物 - Google Patents

可可碱和抗组胺剂的治疗组合物 Download PDF

Info

Publication number
CN102802625A
CN102802625A CN2010800570274A CN201080057027A CN102802625A CN 102802625 A CN102802625 A CN 102802625A CN 2010800570274 A CN2010800570274 A CN 2010800570274A CN 201080057027 A CN201080057027 A CN 201080057027A CN 102802625 A CN102802625 A CN 102802625A
Authority
CN
China
Prior art keywords
theobromine
antihistamine
cough
compositions
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2010800570274A
Other languages
English (en)
Chinese (zh)
Inventor
约翰·布鲁
罗宾·马克·班尼斯特尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Reyes Leather Co.,Ltd. Ethiopia Lancome
Infirst Healthcare Ltd
Original Assignee
Biocopea Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocopea Ltd filed Critical Biocopea Ltd
Publication of CN102802625A publication Critical patent/CN102802625A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
CN2010800570274A 2009-12-14 2010-12-14 可可碱和抗组胺剂的治疗组合物 Pending CN102802625A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0921803.3A GB0921803D0 (en) 2009-12-14 2009-12-14 Drug composition and its use in therapy
GB0921803.3 2009-12-14
PCT/GB2010/052086 WO2011073647A1 (en) 2009-12-14 2010-12-14 Therapeutic combinations of theobromine and an antihistamine

Publications (1)

Publication Number Publication Date
CN102802625A true CN102802625A (zh) 2012-11-28

Family

ID=41667043

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2010800570274A Pending CN102802625A (zh) 2009-12-14 2010-12-14 可可碱和抗组胺剂的治疗组合物

Country Status (18)

Country Link
EP (1) EP2512472A1 (enExample)
JP (2) JP2013513652A (enExample)
CN (1) CN102802625A (enExample)
AU (1) AU2010332495C1 (enExample)
BR (1) BR112012014159A8 (enExample)
CA (1) CA2784215A1 (enExample)
CO (1) CO6541638A2 (enExample)
GB (1) GB0921803D0 (enExample)
IL (1) IL220384A0 (enExample)
MX (1) MX2012006624A (enExample)
NZ (1) NZ600267A (enExample)
PE (1) PE20121538A1 (enExample)
PH (1) PH12012501200A1 (enExample)
RU (1) RU2012129675A (enExample)
SG (2) SG181603A1 (enExample)
UA (1) UA105827C2 (enExample)
WO (1) WO2011073647A1 (enExample)
ZA (1) ZA201204294B (enExample)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103263533A (zh) * 2013-05-31 2013-08-28 杨宏伟 一种治疗咳嗽的可可碱组合物及其用途及其制剂
CN104188998A (zh) * 2014-09-18 2014-12-10 中山大学 一种柚皮苷与盐酸非索非那丁药物组合物及其制剂
CN104224819A (zh) * 2014-09-18 2014-12-24 中山大学 一种柚皮苷与盐酸左西替利嗪药物组合物及其制剂

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10016437B2 (en) 2009-06-16 2018-07-10 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
GB201111485D0 (en) * 2011-07-05 2011-08-17 Biocopea Ltd Drug composition and its use in therapy
US9308211B2 (en) 2009-06-16 2016-04-12 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
US9314465B2 (en) 2009-06-16 2016-04-19 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
GB0910375D0 (en) 2009-06-16 2009-07-29 Biocopea Ltd Drug composition and its use in therapy

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003128549A (ja) * 2001-08-15 2003-05-08 Rohto Pharmaceut Co Ltd 粘膜適用組成物
WO2008002514A2 (en) * 2006-06-26 2008-01-03 Levine Brian M Combination cough treatment compounds and method of treating common coughs

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE59550T1 (de) * 1986-04-17 1991-01-15 Alza Corp Chlorpheniramine therapie.
HUP9700654A2 (hu) 1997-03-26 1999-09-28 Dezső Korbonits Teobromin tartalmú köhögéscsillapító készítmények
JPH10316568A (ja) * 1997-05-13 1998-12-02 Taisho Pharmaceut Co Ltd 医薬組成物
JP2003012514A (ja) * 2001-07-02 2003-01-15 Taisho Pharmaceut Co Ltd 医薬組成物
US20080254029A1 (en) * 2007-04-11 2008-10-16 Alcon Research, Ltd. Use of an Inhibitor of TNFa Plus an Antihistamine to Treat Allergic Rhinitis and Allergic Conjunctivitis

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003128549A (ja) * 2001-08-15 2003-05-08 Rohto Pharmaceut Co Ltd 粘膜適用組成物
WO2008002514A2 (en) * 2006-06-26 2008-01-03 Levine Brian M Combination cough treatment compounds and method of treating common coughs

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103263533A (zh) * 2013-05-31 2013-08-28 杨宏伟 一种治疗咳嗽的可可碱组合物及其用途及其制剂
CN103263533B (zh) * 2013-05-31 2014-11-05 杨宏伟 一种治疗咳嗽的可可碱组合物及其用途及其制剂
CN104188998A (zh) * 2014-09-18 2014-12-10 中山大学 一种柚皮苷与盐酸非索非那丁药物组合物及其制剂
CN104224819A (zh) * 2014-09-18 2014-12-24 中山大学 一种柚皮苷与盐酸左西替利嗪药物组合物及其制剂
CN104224819B (zh) * 2014-09-18 2016-08-17 中山大学 一种柚皮苷与盐酸左西替利嗪药物组合物及其制剂

Also Published As

Publication number Publication date
PE20121538A1 (es) 2012-12-21
CA2784215A1 (en) 2011-06-23
NZ600267A (en) 2013-07-26
IL220384A0 (en) 2012-08-30
WO2011073647A1 (en) 2011-06-23
RU2012129675A (ru) 2014-01-27
SG10201408374WA (en) 2015-01-29
JP6078605B2 (ja) 2017-02-08
AU2010332495B2 (en) 2015-01-22
UA105827C2 (uk) 2014-06-25
JP2013513652A (ja) 2013-04-22
AU2010332495A1 (en) 2012-06-21
CO6541638A2 (es) 2012-10-16
JP2016040280A (ja) 2016-03-24
BR112012014159A2 (pt) 2017-08-29
EP2512472A1 (en) 2012-10-24
PH12012501200A1 (en) 2012-11-26
AU2010332495C1 (en) 2016-02-11
GB0921803D0 (en) 2010-01-27
MX2012006624A (es) 2012-10-05
BR112012014159A8 (pt) 2017-12-26
SG181603A1 (en) 2012-07-30
ZA201204294B (en) 2013-02-27

Similar Documents

Publication Publication Date Title
JP6078605B2 (ja) テオブロミンと抗ヒスタミン剤との治療用組み合わせ剤
JP6118919B2 (ja) テオブロミンとの薬物組み合わせおよび治療におけるその使用
CN103189108A (zh) 用于治疗的可可碱与祛痰剂或粘液溶解剂的组合
JP2016040279A (ja) テオブロミンのうっ血除去剤との組み合わせおよび咳嗽を治療するためのその使用
CN102740853B (zh) 可可碱的药物组合及其在治疗中的用途
AU2015201844B2 (en) Therapeutic Combinations of Theobromine and an Antihistamine
AU2015200654B2 (en) Combination of theobromine with a decongestant and its use for the treatment of cough
AU2015201845B2 (en) Drug combination with theobromine and its use in therapy

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
ASS Succession or assignment of patent right

Owner name: THE FIRST MEDICAL HEALTH CARE CO., LTD.

Free format text: FORMER OWNER: RUISI PIKOU PIYA CO., LTD.

Effective date: 20141210

Owner name: RUISI PIKOU PIYA CO., LTD.

Free format text: FORMER OWNER: BIOCOPEA LTD.

Effective date: 20141210

C41 Transfer of patent application or patent right or utility model
TA01 Transfer of patent application right

Effective date of registration: 20141210

Address after: Dublin, Ireland

Applicant after: InFirst Healthcare Ltd.

Address before: Dublin, Ireland

Applicant before: Reyes Leather Co.,Ltd. Ethiopia Lancome

Effective date of registration: 20141210

Address after: Dublin, Ireland

Applicant after: Reyes Leather Co.,Ltd. Ethiopia Lancome

Address before: London, England

Applicant before: BIOCOPEA Ltd.

RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20121128